Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis
- PMID: 611665
Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis
Similar articles
-
Iron chelating therapy in thalassemia: current problems.Haematologica. 1990 Sep-Oct;75 Suppl 5:84-8. Haematologica. 1990. PMID: 2086385 No abstract available.
-
Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine.Lancet. 1977 May 7;1(8019):977-9. doi: 10.1016/s0140-6736(77)92279-6. Lancet. 1977. PMID: 67469
-
[Further experiences with iron-chelating therapy (desferrioxamine and ascorbic acid) in siderochromatosis and Cooley's disease].Minerva Med. 1978 Mar 17;69(13):811-21. Minerva Med. 1978. PMID: 643223 Italian. No abstract available.
-
Iron metabolism and iron chelation in the thalassaemia disorders.Haematologica. 1990 Sep-Oct;75 Suppl 5:66-71. Haematologica. 1990. PMID: 2086383 Review. No abstract available.
-
The treatment of Cooley's anemia.Haematologica. 1990 Sep-Oct;75 Suppl 5:57-65. Haematologica. 1990. PMID: 2086382 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical